Treatment Guidelines for Bipolar Depression and Schizophrenia
Program Objectives:
To provide updated information to healthcare providers about evidence-based treatment guidelines in the disease states of bipolar depression and schizophrenia
Cardiometabolic Considerations Associated With Serious Mental Illness
Program Objectives:
To identify cardiometabolic risks and contributors to cardiometabolic risks in patients with mental illness
To discuss the cardiometabolic considerations associated with atypical antipsychotics use
To review current treatment guidelines for cardiometabolic monitoring
Drug Discovery and Development in the Pharmaceutical Industry
Program Objectives:
To understand the drug discovery and development process that leads to FDA approval
To understand where components of the drug development process are aligned with the translational science spectrum
To highlight innovative examples of drug discovery and development
Please confirm below to continue:
I confirm that I am a Health Care Professional (HCP) practicing in the United States, or acting on behalf of an HCP. OR
I am a Formulary Decision Maker (FDM) and/or working on behalf of a public or private payer organization to review scientific information to make drug or device selection or acquisition, formulary management, or coverage and reimbursement decisions on a population basis.
Field Medical Opt-In
Share this resource
The information you provide will be used by Sunovion Pharmaceuticals, Inc. in accordance with our Privacy Policy and by parties acting on behalf of Sunovion to send resources. View our Privacy Notice.
